Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 13-Dec-18 4:37 PM View:  | Keryx Biopharmaceuticals Inc. (KERX) | 12-Dec-18 | Disposition | 162,956 | -- | -- | (100%) 162.96K to 0 | |
| 16-Nov-18 8:49 AM View: | Keryx Biopharmaceuticals Inc. (KERX) | 15-Nov-18 | Market Sale | 1,155 | $2.77 | $3,199.35 | (< 1%) 164.11K to 162.96K | (21%) |
| 30-Oct-18 4:07 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 29-Oct-18 | Market Sale | 1,254 | $3.07 | $3,849.78 | (< 1%) 165.37K to 164.11K | (9%) |
| 16-Aug-18 7:11 AM View: | Keryx Biopharmaceuticals Inc. (KERX) | 15-Aug-18 | Market Sale | 1,185 | $3.04 | $3,602.40 | (< 1%) 166.55K to 165.37K | (11%) |
| 31-Jul-18 4:34 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 30-Jul-18 | Market Sale | 2,354 | $3.86 | $9,086.44 | (1%) 168.9K to 166.55K | 13% |
| 16-May-18 4:40 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 15-May-18 | Market Sale | 1,158 | $5.69 | $6,589.02 | (< 1%) 170.06K to 168.9K | 41% |
| 01-May-18 4:16 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 30-Apr-18 | Market Sale | 2,407 | $4.67 | $11,240.70 | (1%) 172.47K to 170.06K | 28% |
| 22-Mar-18 5:31 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 20-Mar-18 | Grant | 41,250 | -- | -- | 31% 131.22K to 172.47K | |
| 16-Feb-18 4:05 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 15-Feb-18 | Market Sale | 5,651 | $4.81 | $27,181.30 | (4%) 136.87K to 131.22K | 30% |
| 31-Jan-18 5:19 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 29-Jan-18 | Market Sale | 2,830 | $4.81 | $13,612.30 | (2%) 139.7K to 136.87K | 30% |
| 31-Oct-17 4:11 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 30-Oct-17 | Market Sale | 2,582 | $6.03 | $15,569.50 | (2%) 142.28K to 139.7K | 44% |
| 01-Aug-17 4:27 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 31-Jul-17 | Market Sale | 1,445 | $7.14 | $10,317.30 | (1%) 143.73K to 142.28K | 53% |
| 31-Jul-17 4:57 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 28-Jul-17 | Market Sale | 1,236 | $6.96 | $8,602.56 | (< 1%) 144.96K to 143.73K | 52% |
| 03-May-17 4:05 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 01-May-17 | Market Sale | 1,441 | $5.97 | $8,602.77 | (< 1%) 146.4K to 144.96K | 44% |
| 01-May-17 4:05 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 28-Apr-17 | Market Sale | 1,219 | $5.89 | $7,179.91 | (< 1%) 147.62K to 146.4K | 43% |
| 15-Mar-17 6:26 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 14-Feb-17 | Grant | 48,750 | -- | -- | 49% 98.87K to 147.62K | |
| 31-Jan-17 4:05 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 30-Jan-17 | Market Sale | 8,447 | $4.65 | $39,278.60 | (8%) 107.32K to 98.87K | 28% |
| 31-Oct-16 4:07 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 28-Oct-16 | Market Sale | 1,237 | $4.44 | $5,492.28 | (1%) 108.56K to 107.32K | 24% |
| 02-Aug-16 5:00 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 29-Jul-16 | Market Sale | 4,935 | $7.36 | $36,321.60 | (4%) 113.49K to 108.56K | 54% |
| 01-Feb-16 6:55 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 28-Jan-16 | Grant | 53,750 | -- | -- | 90% 59.74K to 113.49K | |
| 05-Nov-15 5:01 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 04-Nov-15 | Market Purchase | 1,328 | $5.40 | $7,171.20 | 2% 58.41K to 59.74K | (38%) |
| 05-Nov-15 5:01 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 03-Nov-15 | Market Purchase | 3,672 | $5.30 | $19,457.90 | 7% 54.74K to 58.41K | (37%) |
| 24-Aug-15 6:06 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 21-Aug-15 | Market Purchase | 5,000 | $5.72 | $28,590.00 | 10% 49.74K to 54.74K | (41%) |
| 03-Aug-15 7:30 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 31-Jul-15 | Market Sale | 2,758 | $7.87 | $21,705.50 | (5%) 52.5K to 49.74K | 57% |
| 17-Jun-15 5:18 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 15-Jun-15 | Option Exercise | 6,234 | $15.82 | $98,634.30 | 12% 53.3K to 59.54K | |
| 17-Jun-15 5:18 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 15-Jun-15 | Market Option Sale (Planned) | 6,234 | $66.63 | $415,371.00 | (10%) 59.54K to 53.3K | 75% |
| 17-Jun-15 5:18 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 15-Jun-15 | Market Sale (Planned) | 1,346 | $66.63 | $89,684.00 | (3%) 53.3K to 51.96K | 75% |
| 05-Jun-15 4:03 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 03-Jun-15 | Market Sale | 22,516 | $68.88 | $1,550,900.00 | (42%) 53.3K to 30.79K | 76% |
| 05-Mar-15 5:06 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 03-Mar-15 | Payment of Exercise | 533 | $49.70 | $26,490.10 | (< 1%) 53.84K to 53.3K | 66% |
| 27-Feb-15 4:56 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 26-Feb-15 | Grant | 5,000 | -- | -- | 10% 48.84K to 53.84K | |
| 18-Dec-14 5:15 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 17-Dec-14 | Payment of Exercise | 859 | $40.49 | $34,780.90 | (2%) 49.7K to 48.84K | 59% |
| 21-Aug-14 4:34 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 19-Aug-14 | Grant | 20,000 | -- | -- | 67% 29.7K to 49.7K | |
| 11-Jun-14 4:08 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 11-Jun-14 | Grant | 15,000 | -- | -- | 102% 14.7K to 29.7K | |
| 28-Feb-14 5:40 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 27-Feb-14 | Grant | 3,100 | -- | -- | 27% 11.6K to 14.7K | |
| 17-Dec-13 4:33 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 16-Dec-13 | Payment of Exercise | 654 | $23.23 | $15,192.40 | (5%) 12.25K to 11.6K | 28% |
| 04-Mar-13 4:33 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 28-Feb-13 | Grant | 7,500 | -- | -- | 100% 0 to 7.5K | |
| 06-Dec-12 4:11 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 05-Dec-12 | Option Exercise | 2,500 | -- | -- | 100% 0 to 2.5K | |
| 06-Dec-12 4:11 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 05-Dec-12 | Market Option Sale (Planned) | 2,500 | $14.79 | $36,975.00 | (100%) 2.5K to 0 | (13%) |
| 13-Sep-12 4:02 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 12-Sep-12 | Conversion | 750 | -- | -- | 100% 0 to 0.75K | |
| 13-Sep-12 4:02 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 12-Sep-12 | Market Sale (Planned) | 750 | $15.54 | $11,655.00 | (100%) 0.75K to 0 | (8%) |